N. Filimonova, I. Tishchenko, O. Geyderikh, E. Pokrishko
{"title":"Biopreparations: current application prospects","authors":"N. Filimonova, I. Tishchenko, O. Geyderikh, E. Pokrishko","doi":"10.24959/ubphj.20.289","DOIUrl":"https://doi.org/10.24959/ubphj.20.289","url":null,"abstract":"","PeriodicalId":344772,"journal":{"name":"Ukrainian biopharmaceutical journal","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134027624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Clinical and economic analysis of pharmacotherapy of patients with toxic liver injury in Kharkiv hospitals","authors":"L. Iakovlieva, T. Bahlai","doi":"10.24959/ubphj.20.266","DOIUrl":"https://doi.org/10.24959/ubphj.20.266","url":null,"abstract":"","PeriodicalId":344772,"journal":{"name":"Ukrainian biopharmaceutical journal","volume":"53 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123587175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Y. Naboka, N. P. Zubitska, I. Zupanets, S. Shebeko, I. Otrishko
{"title":"The experimental study of the «Arthritan» drug influence on the induced and spontaneous pain reactions","authors":"Y. Naboka, N. P. Zubitska, I. Zupanets, S. Shebeko, I. Otrishko","doi":"10.24959/ubphj.20.253","DOIUrl":"https://doi.org/10.24959/ubphj.20.253","url":null,"abstract":"and “Nevrin” preparations was 20.8 % and 15.9 %, respectively; the “Nephrolik” preparation did not have a significant analgesic effect. Under conditions of the development of a spontaneous pain reaction in rats with acute gonarthritis, the studied phytocomposition showed a high level of analgesic effect with repeated administrations, the activity of which on the 5th day of the experiment was 41.9 %, which significantly exceeds all other means. The preparations “Arthritan” and “Nevrin” showed activity – 19.1 % and 17.9 %, respectively, and the drug “Nephrolic” – 7.8 %, which is an unreliable result. The high level of analgesic activity of the studied phytocomposition is due to the potentiating interaction of its components such as “Arthritan” and “Nevrin”. Conclusions. The results of the studies allow us to recommend further research of the combined preparation con taining “Arthritan”, “Nevrin” and “Nephrolik” at a ratio of 1 : 1 : 0.5 as a means of chondroprotective, anti-inflammatory and analgesic action in rheumatological desease profile patients.","PeriodicalId":344772,"journal":{"name":"Ukrainian biopharmaceutical journal","volume":"37 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116381520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The study of physicochemical and pharmacotechnological properties of active substances in the composition of sublingual tablets","authors":"O. Yakovenko, O. Ruban","doi":"10.24959/ubphj.19.244","DOIUrl":"https://doi.org/10.24959/ubphj.19.244","url":null,"abstract":"Topicality. Every year there is new evidence of stress effect on everyday life and, as a consequence, the develop ment of systemic diseases (atherosclerosis, coronary heart disease, pathological insomnia), therefore, the creation of an original combination drug for its prevention is a relevant task today. Aim. To conduct pharmacotechnological and physico chemical studies of active pharmaceutical ingredients (API) to select the optimal technology for the production of sublingual tablets. Materials and methods. Glycine and magnesium citrate were chosen as the API, pharmacotechnological and physic-chemical studies of which were carried out in accordance with the requirements of the State Pharmacopoeia of Ukraine. Results and discussion. Crystallographic studies showed a significant difference in the form factor between gly cine and magnesium citrate (0.49 and 0.18, respectively). Both APIs are non-hygroscopic, but magnesium citrate has better flowability (8.48 s/100 g) as opposed to glycine (40.52 s/100 g). The particle size distribution of API was studied (glycine is almost evenly distributed between No. 0, No. 0.1 and No. 0.5 sieves, magnesium citrate is sieved through No. 0 sieve). Conclusions. Based on the results of the studies, the difference in the main technological characteristics of glycine and magnesium citrate is determined. In this regard, there is a need to choose excipients for the production of sublingual tablets by method of direct compression.","PeriodicalId":344772,"journal":{"name":"Ukrainian biopharmaceutical journal","volume":"40 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127947125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}